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More Veggies, Less Breast Cancer:
Unlocking One Secret to Prevention
e all know that eating a balanced diet
is good for us. Susan Lanza-Jacoby,
PhD, the Principal Investigator of the Cancer
Biology and Nutrition Laboratory in the
Department of Surgery, is taking this
conventional wisdom to new scientific
heights. She investigates molecular
abnormalities involved in the development 
of breast cancer and aims to identify novel
strategies using food components for
prevention and treatment.
“We’re striving to show how dietary
supplements can slow down – or even stop –
the incidence of breast cancer, and also
improve the effectiveness of chemotherapy,”
Dr. Jacoby explains, “so that a woman can
take lower doses and also minimize the 
side effects.”
Learning how to prevent or treat tumors 
in the human breast requires working in her
lab with “transgenic” mice – those with
compromised immune systems that receive
implanted tumor cells. The mice are made 
to overexpress a cancer-causing gene 
(HER-2/neu), which inevitably results in
them developing mammary tumors. (This is
the laboratory equivalent of being genetically
predisposed to getting breast cancer.)
“Breast tumors that overexpress this 
gene are aggressive,” says Dr. Jacoby. “They
account for between 20 and 25 percent of all
breast cancer in women, and do not respond
well to standard treatments, which results in
a poor prognosis for the patient.”
Her research suggests that a number 
of dietary factors can have cancer-fighting
properties. Diindolylmethane (DIM) is a
component of certain vegetables, called
cruciferous (such as broccoli, cauliflower,
cabbage, and Brussels sprouts), and members
of Dr. Jacoby’s lab have been observing that it
can decrease growth and even kill breast
cancer cells that result from overexpression
of the HER-2/neu gene.
She explains that mice fed our Western
diets took about 6 to 7 months to develop
breast tumors; whereas when they fed DIM 
to the transgenic mice, it took over a year to
develop the tumors. “This is a significant
delay,” she explains, “Consider the potential
for helping genetically predisposed adolescent
girls delay the onset of cancer until well into
their 50s or 60s.”
Dr. Jacoby is also investigating how 
to develop combined therapies that will
prevent the development of breast tumors.
A multitargeted approach based on the
characteristics of the individual tumor has
provided more effective prevention and
treatment. “We measured the growth of
tumors in the mice, and when we used a
combination of the DIM supplement and
docetaxel, a chemotherapeutic another agent,
there was a significantly slower rate of tumor
growth.” She is also finding that a COX-2
inhibitor, used in combination with other
agents, can prevent the incidence of breast
tumors altogether.
In July Dr. Jacoby was awarded a research
grant from the Pennsylvania Department of
Health to continue her study of the role of the
ErbB and COX-2 signaling pathway in HER-2
breast cancer. Thanks to a grant from the
U.S. Department of Agriculture, she is
developing a teaching module about the role
of nutrition and cancer prevention, which
will mean her exciting findings to date will
have a direct path into patients’ lives.
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How do you define your role?
I meet with patients, families, and
friends of the Department and help to
find a match between what they want
to support and what the various
divisions and physicians need to make
their programs most successful,
whether it’s to expand programs,
pursue innovative research, or enhance
patient care.
What do you like about your position?
I enjoy working with individuals who
are so committed to Jefferson and want
to make a difference by giving back in
some way. It’s exciting to learn from the
patients and their families about the
great impact our Jefferson staff and
surgeons have had on their lives.
What’s a common misconception
about development?
I’m not sure people realize there are
many different ways to give, beyond an
outright cash gift. Appreciated stock,
real estate, and bequests are options,
as well as charitable gift annuities and
charitable trusts, which provide income
during a donor’s lifetime. Congress has
provided a temporary opportunity for
those 70 years of age to make a gift
directly from their IRA. These can be
attractive options for a donor who may
want to earn income, reduce capital
gains or estate taxes, or provide for
their heirs.
What is most satisfying about 
the work you do?
It’s gratifying to see how pleased the
donors are when they see the
difference their generosity makes. It’s
great to help facilitate a process that
strengthens the Department in
achieving its mission.
Dr. Susan Lanza-Jacoby and her team lead groundbreaking studies on the links between 
dietary elements and breast tumors.
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